AlphaYouAB
Insider selling
Anthony Bergmann sold Capricor Therapeutics, Inc. (CAPR) stock
Anthony Bergmann, Chief Financial Officer of Capricor Therapeutics, Inc. (CAPR), sold 25,000 shares of CAPR stock, per an SEC Form 4 filed May 4, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 1, 2026, 3 days before it was made public.
CAPR has moved -71.2% since the trade date, from $30.91 to $8.90 (Sep 21, 2026 close).
- Traded
- May 1, 2026
- Disclosed
- May 4, 2026
- Filing delay
- 3 days
- Price since
- -71.2%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More CAPR insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.